1061 — Essex Bio-Technology Balance Sheet
0.000.00%
Last trade - 00:00
- HK$1.31bn
- HK$1.09bn
- HK$1.71bn
- 94
- 93
- 31
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 484 | 600 | 671 | 543 | 515 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 652 | 516 | 714 | 500 | 637 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,267 | 1,333 | 1,547 | 1,214 | 1,245 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 189 | 280 | 352 | 401 | 406 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,078 | 2,421 | 2,863 | 2,712 | 2,828 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 509 | 606 | 690 | 561 | 811 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 881 | 995 | 1,129 | 981 | 904 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,197 | 1,426 | 1,734 | 1,731 | 1,924 |
Total Liabilities & Shareholders' Equity | 2,078 | 2,421 | 2,863 | 2,712 | 2,828 |
Total Common Shares Outstanding |